Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Impairment of endothelial function in patients with multiple sclerosis.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity.
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.
An Increase in Tolerogenic Dendritic Cell and Natural Regulatory T Cell Numbers during Experimental Autoimmune Encephalomyelitis in Rras-/- Mice Results in Attenuated Disease.
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
MicroRNA dysregulation in multiple sclerosis.
Molecular pathogenesis of neuromyelitis optica.
The role of IFNβ in the treatment of MSand EAE - In the perspective of inflammasomes.
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
Multiple sclerosis: TNF receptor 1 gene variant could explain failure of TNF-blocking drugs in multiple sclerosis.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
More than just multiple sclerosis.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis.
Concepts for regulation of axon integrity by enwrapping glia.
Alemtuzumab treatment of multiple sclerosis.
Adverse socioeconomic position during the life course is associated with multiple sclerosis.

Pages